PVLA SCHEDULE 13G/A: SEC filing
Palvella Therapeutics, Inc.
Filed with the SEC on · accession 0000053417-26-000064
PVLA filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Oct 28, 2026. Palvella Therapeutics, Inc. filed an amended Schedule 13G indicating a passive institutional ownership position. The stock moved +11.0% by the first close after the filing.
Summary of the filing
Palvella Therapeutics, Inc. filed an amended Schedule 13G indicating a passive institutional ownership position. The filing text provided contains only EDGAR directory metadata and no substantive ownership details.
Key details
How PVLA stock reacted
Close before
$132.91
Oct 27, 2026
First close after
+10.95%
$147.47
5 trading days
+15.06%
$152.93
Since filing
+32.36%
$175.92
✦ Ask GOAX AI about this filing — what it means for PVLA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for PVLA?
Click hereFrequently asked questions
What did PVLA file with the SEC on Oct 28, 2026?
PVLA filed a SCHEDULE 13G/A (SEC filing). Palvella Therapeutics, Inc. filed an amended Schedule 13G indicating a passive institutional ownership position. The filing text provided contains only EDGAR directory metadata and no substantive ownership details.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did PVLA stock react to this filing?
PVLA closed at $132.91 before the filing and $147.47 on Oct 28, 2026 (+10.95%). Five trading days later: $152.93 (+15.06%).
Other PVLA SEC filings
Get alerts when PVLA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days